- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04047511
Virtual Therapy as a Method Supporting Treatment of Late-Life Depression
Immersive Virtual Therapy as a Method Supporting the Non-Farmacological Treatment of Late-Life Depression
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Depressive disorders are frequent and can either first be manifested at a younger age and recurrent during later life or have an onset beyond 60 years (late-life depression). The multifactorial genesis of depression in old age includes psychosocial, vascular and metabolic factors and requires multimodal and multi-professional therapy including physical activity and psychosocial interventions. However, there is still a percentage of older people who do not show improvement in depressive symptoms.
In recent years, various types of virtual reality are gaining in popularity, primarily because of the availability and ease of use. A systematic review from 2018 concluded that VR treatment had moderate to large effects in anxiety and depression, compared to controls and it could be another effective choice available to clinicians and patients.
Therefore, the aim of this project was to evaluate the effectiveness of virtual therapy in the elderly, in whom the previous multimodal therapeutic program has not brought the expected results.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Lower Silesia
-
Wrocław, Lower Silesia, Poland, 50-240
- Foundation for Senior Citizen Activation SIWY DYM
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- GDS≥10 or HADS-A≥8 or HADS-D≥8
Exclusion Criteria:
- cognitive impairment (MMSE<24) or aphasia and a serious loss of sight or hearing that makes it impossible to assess cognitive functions based on MMSE;
- contraindications for virtual therapy (epilepsy, vertigo, eyesight impairment);
- substance abuse;
- participation in another therapeutic project or individual psychotherapy;
- antidepressant treatment;
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Virtual Reality
Twice a week, for a 4 consecutive weeks:
|
As a virtual reality source, VRTierOne device (Stolgraf®) were used.
Thanks to using head mounted display and the phenomenon of total immersion "VRTierOne" Stolgraf® provides an intense visual, auditory and kinesthetic stimulation.
It can have a calming and mood-improving effect or help the patients recognize their psychological resources and motivate to the rehabilitation process.
In the virtual therapeutic garden there are a rich set of symbols and metaphors based on Ericksonian Psychotherapy approach.
The most important is the Garden of Revival which symbolizes the patient's health.
It used to be full of life and energy, now it is neglected, requires work to be revived.
In the therapeutic process day by day, the lector (therapist) tells the patient a symbolic story about his/her situation.
By performing tasks in the virtual garden, the patient influences the course of this story, becomes an active participant of the therapeutic process and sees the effects his work.
A single session of general fitness training will be composed of low-intensity, general-fitness exercises.
Most of the exercises will be carried out in a sitting position and standing positon.
The session will contain aerobic (general warm-up), musculo-articular (strengthening muscles and joints range of motion) and stabilizing exercises (improve spatio-visual coordination).
Perception of effort will be monitored using the Borg 6-20 rating the perceived exertion.
Conducted by a physiotherapist in group form.
|
Active Comparator: Control
Twice a week, for a 4 consecutive weeks:
|
A single session of general fitness training will be composed of low-intensity, general-fitness exercises.
Most of the exercises will be carried out in a sitting position and standing positon.
The session will contain aerobic (general warm-up), musculo-articular (strengthening muscles and joints range of motion) and stabilizing exercises (improve spatio-visual coordination).
Perception of effort will be monitored using the Borg 6-20 rating the perceived exertion.
Conducted by a physiotherapist in group form.
A single sesstion will contain mini-lectures about mental well-being and psychohygiene, conduced by a psychotherapist in group form.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The Geriatric Depression Scale (GDS)
Time Frame: 15 minutes
|
The Geriatric Depression Scale is a self-report 30-items measure of well-being and mood in older adults.
The patient responds in a "Yes/No" format.
Scoring ranges from 0 to 30, where 11 and more means mood disorders.
The higher score means the greater depression.
|
15 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Perception of Stress Questionnaire (PSQ)
Time Frame: 30 minutes
|
The Perception of Stress Questionnaire (PSQ) is a 27-item scale scoring from 1 to 5 for each item.
21 items examine the level of stress in the area of emotional tension, external stress and intrapsychic stress, and 6 items refer to the lie scale.
The global scoring for perception of stress ranges from 21 to 105 with a cut-off point of 60 for high level of perceived stress.
The higher the score, the greater the sense of stress.
PSQ will be performed at the beginning and after four weeks of treatment.
|
30 minutes
|
Hospital Anxiety and Depression Scale (HADS)
Time Frame: 30 minutes
|
The Hospital Anxiety and Depression Scale (HADS) is a fourteen-item scale scoring from 0 to 3 for each item.
The first seven items relate to anxiety (HADS-A), and the remaining seven items relate to depression (HADS-D).
The global scoring ranges from 0 to 42 with a cut-off point of 8/21 for anxiety and 8/21 for depression.
The higher the score, the greater anxiety or depression symptoms.
|
30 minutes
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Błażej Cieślik, MSc, University School of Physical Education, Wroclaw, Poland
Publications and helpful links
General Publications
- Freeman D, Reeve S, Robinson A, Ehlers A, Clark D, Spanlang B, Slater M. Virtual reality in the assessment, understanding, and treatment of mental health disorders. Psychol Med. 2017 Oct;47(14):2393-2400. doi: 10.1017/S003329171700040X. Epub 2017 Mar 22.
- Maples-Keller JL, Bunnell BE, Kim SJ, Rothbaum BO. The Use of Virtual Reality Technology in the Treatment of Anxiety and Other Psychiatric Disorders. Harv Rev Psychiatry. 2017 May/Jun;25(3):103-113. doi: 10.1097/HRP.0000000000000138.
- Li J, Theng YL, Foo S. Game-based digital interventions for depression therapy: a systematic review and meta-analysis. Cyberpsychol Behav Soc Netw. 2014 Aug;17(8):519-27. doi: 10.1089/cyber.2013.0481. Epub 2014 May 8.
- McCann RA, Armstrong CM, Skopp NA, Edwards-Stewart A, Smolenski DJ, June JD, Metzger-Abamukong M, Reger GM. Virtual reality exposure therapy for the treatment of anxiety disorders: an evaluation of research quality. J Anxiety Disord. 2014 Aug;28(6):625-31. doi: 10.1016/j.janxdis.2014.05.010. Epub 2014 Jun 7.
- Valmaggia LR, Latif L, Kempton MJ, Rus-Calafell M. Virtual reality in the psychological treatment for mental health problems: An systematic review of recent evidence. Psychiatry Res. 2016 Feb 28;236:189-195. doi: 10.1016/j.psychres.2016.01.015. Epub 2016 Jan 12.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 59/0203/S/02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Lawson Health Research InstituteTerminated
Clinical Trials on VRTierOne
-
University School of Physical Education in WroclawFoundation for Senior Citizen Activation SIWY DYMCompletedDepression | Anxiety | Depressive SymptomsPoland